SCIE期刊Regenerative Medicine 2024/2025影响因子:2.416 (REGEN MED) (1746-0751). (CELL & TISSUE ENGINEERING)(细胞与组织工程)Science Ci

显示全部楼层 · 发表于 2025-3-23 15:03:40

Submitted on: 28 August 2022. Revised on: 29 September 2022. Accepted on: 17 October 2022. Regenerative Medicine---FUTURE MEDICINE LTD

显示全部楼层 · 发表于 2025-3-23 20:21:20

Submitted on: 01 August 2018. Revised on: 20 August 2018. Accepted on: 15 September 2018. Regenerative Medicine

显示全部楼层 · 发表于 2025-3-23 23:42:02

显示全部楼层 · 发表于 2025-3-24 05:48:39

Submitted on: 05 April 2017. Revised on: 03 May 2017. Accepted on: 24 May 2017. Regenerative Medicine---FUTURE MEDICINE LTD

显示全部楼层 · 发表于 2025-3-24 08:05:25

Submitted on: 24 February 2001. Revised on: 30 March 2001. Accepted on: 05 April 2001. Regenerative Medicine

显示全部楼层 · 发表于 2025-3-24 11:47:24

显示全部楼层 · 发表于 2025-3-24 16:13:42

显示全部楼层 · 发表于 2025-3-24 19:41:03

Submitted on: 12 March 2012. Revised on: 11 April 2012. Accepted on: 20 April 2012. Regenerative Medicine

显示全部楼层 · 发表于 2025-3-25 00:11:28

Submitted on: 09 March 2003. Revised on: 19 April 2003. Accepted on: 30 April 2003. Regenerative Medicine---FUTURE MEDICINE LTD

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 11:23
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved